Top rankings include Mount Sinai Morningside and The Mount Sinai Hospital, with stroke rehabilitation a standout program
Research conducted at Mount Sinai and Yale confirms long COVID is a biological disease by showing blood biomarkers that can predict who has it
A team of leading clinicians, engineers, and neuroscientists has made a groundbreaking discovery in the field of treatment-resistant depression.
First systematic study of the subject finds that more than half of unsalaried community health care workers in dual-cadre programs experienced unfair treatment in the workplace
Mount Sinai study focused on Harlem preschools emphasizes the need for specialized health promotion programs in classrooms starting at an early age
New method can predict risks of cardiovascular disease, mortality in sleep apnea patients
Agreement aims to improve patient care and outcomes on a global scale
Results from a large-scale clinical trial results could increase usage of high resolution imaging for guiding interventional coronary procedures
Mount Sinai study identifies most effective and safest outpatient labor induction methods, potentially reducing hospital stays and increasing hospital efficiency in use of resources
The Icahn School of Medicine at Mount Sinai will help lead and launch the first clinical trial focusing on women and minority populations to determine which coronary revascularization procedure best improves their survival and quality of life.
Babies are more likely to be born prematurely when either their father or mother has had a psychiatric diagnosis, according to a study.
The Icahn School of Medicine at Mount Sinai in New York, NY is pleased to announce that CastleVax, Inc. has completed enrollment and a preliminary analysis of a phase 1 trial of its licensed Newcastle disease virus (NDV)-based COVID-19 booster vaccine.
Findings may help inform the development of intervention and prevention strategies
Study represents a major milestone toward health equity for underrepresented populations in Alzheimer’s disease research
The Icahn School of Medicine at Mount Sinai has launched the Center for Ophthalmic Artificial Intelligence and Human Health, the first of its kind in New York and one of the first in the United States.
Mount Sinai Health System patients will experience greater access to care, fast identification of symptoms, efficient online search and connection to specialists, and easy appointment scheduling thanks to newly launched Digital Experience tools accessible on their smartphones or computers.
Principal Investigator: Louis R. Pasquale, MD, FARVO, Deputy Chair for Ophthalmology Research for the Mount Sinai Health System Co-First Authors: Oana A. Zeleznik, PhD, Instructor in Medicine at Brigham and Women’s Hospital and Jae H. Kang, ScD, Assistant Professor of…
Sleep medicine experts from the Mount Sinai Health System are presenting new research at SLEEP 2023, the 37th annual meeting of the Associated Professional Sleep Societies running until June 7 in Indianapolis.
Experts say medication commonly used to treat insomnia may also be a therapeutic option for the condition known as REM sleep behavior disorder
First Mount Sinai cardiologist to hold this prestigious position
A machine learning-based model that enables medical institutions to predict the mortality risk for individual cardiac surgery patients has been developed by a Mount Sinai research team, providing a significant performance advantage over current population-derived models.
First-generation bioresorbable vascular scaffolds (BVS) may be just as effective as drug-eluting metallic stents, which are currently the standard treatment for heart disease patients undergoing percutaneous coronary intervention (PCI).
Institute, including three new centers, will lead research to foster novel discoveries and explore new treatments for a range of diseases from leukemia to Alzheimer’s disease.
The Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai will expand its research training program in skin biology with support from a five-year, $1.3 million T32 grant from the National Institutes of Health (NIH) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).
The grand opening of the Center for Engineering and Precision Medicine (CEPM), a partnership between Rensselaer Polytechnic Institute (RPI) and the Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai), was held March 29, 2023 at the Hudson Research Center (HRC) at 619 West 54th Street. The center is the latest in a 10+ year partnership between RPI, a world-renowned technological research university known for its engineering, technology, and science programs, and Icahn Mount Sinai, the academic arm of the Mount Sinai Health System, which includes eight hospitals and a vast network of ambulatory practices throughout the greater New York City region.
The Mount Sinai Health System has announced the Growth in Operations, Administrations, and Leadership Society (GOALS), an initiative to increase the representation of Black men at the middle and upper levels of management by creating pathways for career advancement through networking, mentorship, and advancement opportunities. This initiative furthers Mount Sinai’s continuing commitment to growing a diverse workplace and providing equitable care for patients.
Reproductive health experts from the Mount Sinai Health System are presenting research at the 70th Annual Meeting of the Society for Reproductive Investigation (SRI) in Brisbane, Australia from March 21-25.
In an effort to expand equitable health care throughout New York City, the Digital and Technology Partners (DTP) department at Mount Sinai Health System is collaborating with The New York Public Library (NYPL) to support access to health services through electronic information or technologies—better known as telehealth—and digital literacy skills.
A novel type of therapy, known as ANGPTL3 inhibitor therapy, was effective in lowering triglycerides in certain types of patients with severe hypertriglyceridemia (sHTG) who had a prior episode(s) of acute pancreatitis. sHTG is a well-established risk factor for recurrent episodes of acute pancreatitis. These high-risk patients were the focus of a phase 2 study that was led by the Icahn School of Medicine at Mount Sinai and sponsored and funded by Regeneron.
High-dose anticoagulation can reduce deaths by 30 percent and intubations by 25 percent in hospitalized COVID-19 patients who are not critically ill when compared to the standard treatment, which is low-dose anticoagulation.
Breakthrough findings from study led by Mount Sinai researcher could improve outcomes for high-risk patients
Mount Sinai Health System and Memorial Sloan Kettering Cancer Center researchers have developed a new drug delivery approach that uses nanoparticles to enable more effective and targeted delivery of anti-cancer drugs to treat brain tumors in children.
Researchers from the Icahn School of Medicine at Mount Sinai have generated the first induced pluripotent stem cells (iPSCs) from bats, gaining valuable insights into the close relationship between bats and viruses.
ROCKVILLE, MD – Approximately three million Americans suffer from opioid use disorder, and every year more than 80,000 Americans die from overdoses. Opioid drugs, such as heroin, fentanyl, oxycodone and morphine, activate opioid receptors. Activating mu-opioid receptors leads to pain relief and euphoria, but also physical dependence and decreased breathing, the latter leading to death in the case of drug overdose.
The Arnhold Institute for Global Health at Mount Sinai has received $8 million from the Arnhold Foundation, enabling doctors, researchers, and students to advance its already-strong base of clinical education programs, training, research, and care services to address the world’s leading health issues and improve global health systems.
Analysis reveals similar changes in the brain’s functioning in both humans and mouse models
MEDIA ADVISORY UNDER EMBARGO UNTIL 11:00AM ET, MONDAY, JANUARY 30, 2023 Paper Title: Progenitor-derived endothelin controls dermal sheath contraction for hair follicle regression Journal: Nature Cell Biology (January 30, 2023) Authors: Michael Rendl, MD, Professor of Cell, Developmental and Regenerative Biology,…
Doctors warn about lack of knowledge of administering CPR, especially in high-risk groups, and the rise of stress-related heart issues
Cedars-Sinai has appointed Michael E. Farkouh, MD, MSc, as associate dean for Research and Clinical Trials and professor of Cardiology, effective March 1, 2023. A clinical cardiologist and epidemiologist, Farkouh is internationally known for his academic leadership and distinguished record of diabetes and cardiovascular disease clinical trials.
Two separate eye diseases may contribute to age-related macular degeneration (AMD), a leading cause of blindness in the United States, according to a new study from New York Eye and Ear Infirmary of Mount Sinai.
Peter Heeger, MD, Justin Steggerda, MD, Hirsh Trivedi, MD, and Lorenzo Zaffiri, MD, PhD, have all recently joined the Cedars-Sinai Comprehensive Transplant Center.
MEDIA ADVISORY UNDER EMBARGO UNTIL DECEMBER 21, 2022 in Cell Systems Corresponding Authors: Elena Zaslavsky, PhD, Associate Professor of Neurology, Icahn School of Medicine at Mount Sinai; Steven H. Kleinstein, PhD, Anthony Brady Professor of Pathology at Yale School of…
Study is one of the first to associate long COVID symptoms with changes in gene expression during acute COVID-19
Unique program keeps patients with less severe conditions out of the Emergency Department, saving them time and money
Physician-scientist Fanny Elahi, MD, PhD, to lead research team in collaboration with non-profit organization
Inflammatory response linked to amyloid plaque buildup
Mount Sinai Heart expands leadership
Renowned preterm birth expert to lead efforts to improve women’s health and educate and empower women researchers
A novel metric that estimates our “burden,” or cumulative exposure, to a family of thousands of synthetic chemicals that we encounter in everyday life with potentially adverse health impacts, has been created by a team of researchers at Mount Sinai.
Award honors health organizations using information technology to enhance health care and outcomes